CN1OC[C@@H]2CN(C(=S)NCCc3ccccc3)[C@H](c3ccccc3Br)C[C@@H]21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?